Closing Bell: Knight Therapeutics Inc up on Thursday (GUD)
Today, Knight Therapeutics Inc shares closed at $5.68 after opening the day at $5.59. It traded at a low of $5.56 to a high of $5.73.
The price boosted 1.61 percent from the previous day's close of $5.59.
During the day across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.
Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).
A total of 44,527 shares was traded during the last trading day, with total trades of 251, with an average volume of 45,901 over the last 5 days.
The TSX market on the whole today saw 3,490 price advancers against 1,736 declines and 92 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 16.39 percent in 52 weeks, while they have raised 9.44% year-to-date.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $566.69 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
